49 GHP Q2 2026 reated by the brilliant mind behind PainScript, Potomac Psychiatry, and Root Cause Psychiatry, HoloMD is a Remote Therapeutic Monitoring (RTM) platform designed to support mental health providers between patient visits. Dr. Bruce Kehr launched HoloMD in 2024, aiming to position the platform as a trusted tool for millions of patients and practitioners. The HoloMD team works with outpatient mental health practices, psychiatrists, therapists, and behavioural health organisations to extend care beyond the clinic through structured patient engagement and real-time clinical insight. The platform enables daily patient check-ins, surfaces meaningful trends, and routes actionable insights to clinicians, helping them to make more informed decisions and intervene earlier when needed. “A key differentiator for HoloMD is that we are not attempting to replace clinicians. Our focus is on supporting them with better information, earlier signals, and structured workflows. The goal is to improve patient outcomes by enabling more timely and informed care decisions.” Dr. Holo serves as a caring companion that accompanies patients on their journey toward achieving mental wellness. It conducts a unique conversation with each patient between clinic visits and will alert clinical monitoring staff if a patient shows signs of deteriorating. It bases conversations upon their unique history and clinical presentation, taking into account prior conversations and new clinical information. “We prioritise a Human+AI approach, ensuring every patient interaction is supported by structured oversight and clear escalation pathways,” Dominic told us. “Our focus is increasing visibility into patient wellbeing between visits while reducing burdens on clinicians. Our system is designed to surface insights, not replace clinicians.” The psychiatric agent is a secure solution, fully compliant with HIPAA, HITECH, and other relevant regulations. It is trained on hundreds of thousands of peer-reviewed scientific journal articles, medical records, blog posts, and podcasts created by awardwinning clinicians. Leveraging this training, Dr. Holo combines the expertise of renowned scientists and clinicians across eight fields Mental health care often lacks continuous data, which leaves providers to make decisions based on limited snapshots. HoloMD has set out on a mission to transform the current state of the mental health care landscape by combining decades of awardwinning clinical psychiatry with cutting-edge AI to empower clinicians and support patients with compassionate, continuous care. We heard more from Dominic Fabrizio, Vice President of Marketing and Customer Success, as HoloMD is named in the GHP Mental Health Awards 2026. HoloMD related to holistic, Root Cause Psychiatry. Its advanced machine learning capabilities mean that Dr. Holo will continue to evolve, becoming an even smarter, more effective psychiatric agent as time goes on. Staying ahead requires HoloMD to play close attention to the market. The team has observed increasing demand for scalable mental health solutions, combined with clinician shortages and growing complexity in patient needs. At the same time, reimbursement models like RTM are evolving to support more continuous care. HoloMD is adapting to these changes in a number of ways: aligning its platform with reimbursement pathways, enhancing data-driven insights, and ensuring that its solution integrates seamlessly into clinical workflows. As HoloMD looks to the future, Dominic concluded, “2025 reinforced the importance of adoption and measurable outcomes over features. In 2026, we are focusing on scaling across larger behavioural organisations, expanding our clinical insight capabilities, and further aligning with reimbursement pathways. We are also continuing to refine how we deliver actionable data to clinicians, ensuring the platform drives both clinical and financial value.” Since its inception, the team at HoloMD has been fiercely dedicated to mitigating the suffering of people who are struggling with mental health conditions, and the loved ones who are also on their journey. Through dedicated research, constant evolution, and compassionate care, the platform has become a beacon of hope for countless individuals and, for this reason, we at Global Health & Pharma Magazine would like to celebrate HoloMD with recognition as the USA’s Mental Health Tech Innovators of the Year 2026 and the USA’s Best AI-Powered Remote Therapeutic Monitoring Specialists 2026. Contact: Dominic Fabrizio Company: HoloMD Web Address: www.holomd.ai C Mental Health Tech Innovators of the Year 2026 – USA & Best AIPowered Remote Therapeutic Monitoring Specialists 2026 – USA
RkJQdWJsaXNoZXIy MTUyMDQwMA==